Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma

BACKGROUND: Despite improved survival for the patients with diffuse large B-cell lymphoma (DLBCL), the prognosis after relapse is poor. The aim was to identify molecular events that contribute to relapse and treatment resistance in DLBCL. METHODS: We analysed 51 prospectively collected pretreatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Taskinen, Minna, Louhimo, Riku, Koivula, Satu, Chen, Ping, Rantanen, Ville, Holte, Harald, Delabie, Jan, Karjalainen-Lindsberg, Marja-Liisa, Björkholm, Magnus, Fluge, Øystein, Pedersen, Lars Møller, Fjordén, Karin, Jerkeman, Mats, Eriksson, Mikael, Hautaniemi, Sampsa, Leppä, Sirpa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953211/
https://www.ncbi.nlm.nih.gov/pubmed/24625556
http://dx.doi.org/10.1371/journal.pone.0091031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953211/
https://www.ncbi.nlm.nih.gov/pubmed/24625556
http://dx.doi.org/10.1371/journal.pone.0091031

Ejemplares similares